Role of aripiprazole in treatment-resistant schizophrenia

References

• World Health OrganizationThe Global Burden of Disease: 2004 update Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.htmlAccessed February 16, 2012
   Google Scholar
• KaneJMCorrellCUPast and present progress in the pharmacologic treatment of schizophreniaJ Clin Psychiatry20107191115112420923620
   PubMed Web of Science ®Google Scholar
• ConleyRRBuchananRWEvaluation of treatment-resistant schizophreniaSchizophr Bull19972346636749366002
   PubMed Web of Science ®Google Scholar
• SuzukiTRemingtonGMulsantBHTreatment resistant schizophrenia and response to antipsychotics: a reviewSchizophr Res20111331–3546222000940
   PubMed Web of Science ®Google Scholar
• KaneJHonigfeldGSingerJMeltzerHClozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazineArch Gen Psychiatry19884597897963046553
   PubMed Web of Science ®Google Scholar
• MortimerAMSinghPShepherdCJPuthiryackalJClozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real worldClin Schizophr Relat Psychoses201044495520643629
   PubMedGoogle Scholar
• American Psychiatric AssociationPractice Guideline for the Treatment of Patients with SchizophreniaSecond Edition Available from: http://psychiatryonline.org/content.aspx?bookid=28&sectionid=1665359Accessed February 16, 2012
   Google Scholar
• National Institute for Clinical ExcellenceSchizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care2009NICE clinical guideline 82 Available from: http://guidance.nice.org.uk/CG82/NICEGuidance/pdf/EnglishAccessed on February 16, 2012
   Google Scholar
• WahlbeckKCheineMEssaliAAdamsCEvidence of clozapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trialsAm J Psychiatry1999156799099910401441
   PubMed Web of Science ®Google Scholar
• McEvoyJPLiebermanJAStroupTSEffectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatmentAm J Psychiatry2006163460061016585434
   PubMed Web of Science ®Google Scholar
• CiprianiABosoMBarbuiCClozapine combined with different antipsychotic drugs for treatment resistant schizophreniaCochrane Database Syst Rev20093CD00632419588385
   PubMed Web of Science ®Google Scholar
• NielsenJDamkierPLublinHTaylorDOptimizing clozapine treatmentActa Psychiatr Scand2011123641142221534935
   PubMed Web of Science ®Google Scholar
• BarnesTRMcEvedyCJNelsonHEManagement of treatment resistant schizophrenia unresponsive to clozapineBr J Psychiatry199631Suppl3140
   Web of Science ®Google Scholar
• LiebermanJAStroupSTMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med2005353121209122316172203
   PubMed Web of Science ®Google Scholar
• MullinsDCObeidatNACuffelBJNaradzayJLoebelADRisk of discontinuation of atypical agents in the treatment of schizophreniaSchizophr Res2008981–381517596914
   PubMed Web of Science ®Google Scholar
• LindenmayerJPLiu-SeifertHKulkarniPMMedication non-adherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseJ Clin Psychiatry200970799099619497244
   PubMed Web of Science ®Google Scholar
• GuoXFangMZhaiJEffectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic studyPsychopharmacology (Berl)2011216447548421369751
   PubMed Web of Science ®Google Scholar
• XiangYTWangCYWengYZPredictors of relapse in Chinese schizophrenia patients: a prospective, multi-center studySoc Psychiatry Psychiatr Epidemiol201146121325133021046070
   PubMed Web of Science ®Google Scholar
• MelnikTSoaresBGPugaMEAtallahANEfficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviewsSao Paulo Med J2010128314116620963366
   PubMed Web of Science ®Google Scholar
• CorrellCURummel-KlugeCCorvesCKaneJMLeuchtSAntipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trialsSchizophr Bull200935244345718417466
   PubMed Web of Science ®Google Scholar
• TaylorDMSmithLGeeSHNielsenIAugmentation of clozapine with a second antipsychotic – a meta-analysisActa Psychiatr Scand20121251152422077319
   PubMed Web of Science ®Google Scholar
• PorcelliSBalzarroBSerrettiAClozapine resistance: augmentation strategiesEur Neuropsychopharmacol201222316518221906915
   PubMed Web of Science ®Google Scholar
• BurrisKDMolskiTFXuCAripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsJ Pharmacol Exp Ther2002302138138912065741
   PubMed Web of Science ®Google Scholar
• JordanSKoprivicaVChenRTottoriKKikuchiTAltarCAThe antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptorEur J Pharmacol2002441313714012063084
   PubMed Web of Science ®Google Scholar
• StipETourjmanVAripiprazole in schizophrenia and schizoaffective disorder: a reviewClin Ther201032Suppl 1S3S2020152550
   PubMed Web of Science ®Google Scholar
• KaneJMCarsonWHSahaAREfficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorderJ Clin Psychiatry200263976377112363115
   PubMed Web of Science ®Google Scholar
• MarderSRMcQuadeRDStockEAripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trialsSchizophr Res2003612–312312612729864
   PubMed Web of Science ®Google Scholar
• KasperSLermanMNMcQuadeRDEfficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophreniaInt J Neuropsychopharmacol20036432533714609439
   PubMed Web of Science ®Google Scholar
• PigottTACarsonWHSahaARTorbeynsAFStockEGIngenitoGGAripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week studyJ Clin Psychiatry20036491048105614628980
   PubMed Web of Science ®Google Scholar
• PotkinSGSahaARKukawaMJAripirazole, an antipsychotic with a novel mode of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorderArch Gen Psychiatry200360768169012860772
   PubMed Web of Science ®Google Scholar
• BelgamwarRBEl-SayehHGAripiprazole versus placebo for schizophreniaCochrane Database Syst Rev20118CD00662221833956
   PubMed Web of Science ®Google Scholar
• KomossaKRummel-KlugeCSchmidFAripiprazole versus other atypical antipsychotics for schizophreniaCochrane Database Syst Rev20094CD00656919821375
   PubMed Web of Science ®Google Scholar
• LeuchtSKomossaKRummel-KlugeCA meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophreniaAm J Psychiatry2009166215216319015230
   PubMed Web of Science ®Google Scholar
• BhattacharjeeJEl-SayehHGAripiprazole versus typical antipsychotic drugs for schizophreniaCochrane Database Syst Rev20083CD00661718646161
   PubMed Web of Science ®Google Scholar
• BlondeLKanHJGuttermanEMPredicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of careJ Clin Psychiatry200869574148818435564
   PubMed Web of Science ®Google Scholar
• BarakYAizenbergDSwitching to aripiprazole as a strategy for weight reduction: a metaanalysis in patients suffering from schizophreniaJ Obesity20112011898013
   Google Scholar
• KaneJMMeltzerHYCarsonWHJrMcQuadeRDMarcusRNSanchezRAripiprazole Study GroupAripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind comparison study versus perphenazineJ Clin Psychiatry200768221322317335319
   PubMed Web of Science ®Google Scholar
• Alvarez-JiménezMGonzález-BlanchCCrespo-FacorroBAntipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisalCNS Drugs200822754756218547125
   PubMed Web of Science ®Google Scholar
• GentileSA systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazoleNeuropsychiatric Dis Treat20095117125
   PubMed Web of Science ®Google Scholar
• KessingLVThomsenAFMogensenUBAndersenPKTreatment with antipsychotics and the risk of diabetes in clinical practiceBr J Psychiatry2010197426627120884948
   PubMed Web of Science ®Google Scholar
• Rummel-KlugeCKomossaKSchwarzSHead-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysisSchizophr Res20101232–322523320692814
   PubMed Web of Science ®Google Scholar
• ChungAKChuaSEEffects on prolongation of Bazett’s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysisJ Psychopharmacol201125564666620826552
   PubMed Web of Science ®Google Scholar
• ShimJCShinJGKellyDLAdjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trialAm J Psychiatry200716491404141017728426
   PubMed Web of Science ®Google Scholar
• HanssensLL’ItalienGLozeJYMarcusRNPansMKerselaersWThe effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)BMC Psychiatry200889519102734
   PubMed Web of Science ®Google Scholar
• AzekawaTOhashiSItamiAComparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorderNeuropsychiatr Dis Treat2011769169522128254
   PubMed Web of Science ®Google Scholar
• RiedelMSchennach-WolffRMusilRNeurocognition and its influencing factors in the treatment of schizophrenia – effects of aripiprazole, olanzapine, quetiapine and risperidoneHum Psychopharmacol201025211612520196179
   PubMed Web of Science ®Google Scholar
• LiemburgEAlemanABousJHollanderKKnegteringHAn open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-beingPharmacopsychiatry201144310911321432752
   PubMed Web of Science ®Google Scholar
• SchirmbeckFEsslingerCRauschFEnglischSMeyer-LindenbergAZinkMAntiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophreniaPsychol Med201141112361237321466748
   PubMed Web of Science ®Google Scholar
• GlickIDPoyurovskyMIvanovaOKoranLMAripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patientsJ Clin Psychiatry200869121856185919026264
   PubMed Web of Science ®Google Scholar
• SchönfelderSSchirmbeckFWaltereitREnglischSZinkMAripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophreniaClin Neuropharmacol201134625625722104635
   PubMed Web of Science ®Google Scholar
• EnglischSEsslingerCIntaDClozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazoleClin Neuropharmacol200932422722919644230
   PubMed Web of Science ®Google Scholar
• PetersBde HaanLRemission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazoleProg Neuropsychopharmacol Biol Psychiatry20093381576157719766686
   PubMed Web of Science ®Google Scholar
• RochaFLHaraCBenefits of combining aripiprazole to clozapine: three case reportsProg Neuropsychopharmacol Biol Psychiatry20063061167116916647796
   PubMed Web of Science ®Google Scholar
• ZinkMKnopfUKuwilskyAManagement of clozapine-induced obsessive-compulsive symptoms in a man with schizophreniaAust N Z J Psychiatry200741329329417464712
   PubMed Web of Science ®Google Scholar
• DesarkarPDasANizamieSHAripiprazole-induced obsessive-compulsive disorder: a report of 2 casesJ Clin Psychopharmacol200727330530617502782
   PubMed Web of Science ®Google Scholar
• ChangKYWuYFAripiprazole-associated rhabdomyolysis in a patient with schizophreniaJ Neuropsychiatry Clin Neurosci2011233E5121948930
   PubMed Web of Science ®Google Scholar
• NairAGNairAGGeorgeRJBiswasJGandhiRAAripiprazole induced transient myopia: A case report and review of literatureCutan Ocul Toxicol2012311747621830909
   PubMed Web of Science ®Google Scholar
• CitromeLA review of aripirazole in the treatment of patients with schizophrenia or bipolar I disorderNeuropsychiatric Dis Treat20062427443
   PubMedGoogle Scholar
• ZacherJLHatchettADAripiprazole-induced movement disorderAm J Psychiatry2006163116016116390909
   PubMed Web of Science ®Google Scholar
• De SchutterPBouckaertFPeuskensJAripiprazole-induced parkin-sonism in a 64-year-old female patient diagnosed with bipolar disorderTijdschr Psychiatr2011535299303 Dutch21538299
   PubMedGoogle Scholar
• OnoSSuzukiYShindoMImprovement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literatureJ Clin Pharm Ther10242011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• DesarkarPThakurASinhaVKAripiprazole-induced acute dystoniaAm J Psychiatry200616361112111316741220
   PubMed Web of Science ®Google Scholar
• HendersonJBLabbateLWorleyMA case of acute dystonia after single dose of aripiprazole in a man with cocaine dependenceAm J Addict200716324417612831
   PubMed Web of Science ®Google Scholar
• McLarenJLCaubleSBarnettRJAripiprazole induced acute dystonia after discontinuation of a stimulant medicationJ Clin Psychopharmacol2010301777820075654
   PubMed Web of Science ®Google Scholar
• SolomonSGuptaSJesudasanJTemporomandibular dislocation due to aripiprazole induced dystoniaBr J Clin Pharmacol201070691491521175449
   PubMed Web of Science ®Google Scholar
• OommenEChandPKSharmaPSAripiprazole-induced tardive dystoniaPrim Care Companion J Clin Psychiatry20068637837917245464
   PubMedGoogle Scholar
• DuggalHSAripiprazole-induced improvement in tardive dyskinesiaCan J Psychiatry2003481177177214733461
   PubMed Web of Science ®Google Scholar
• SharmaARamaswamySDewanVKResolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazolePrim Care Companion J Clin Psychiatry2005713615841193
   PubMedGoogle Scholar
• KaneJMBarnesTRCorrellCUEvaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJ Psychopharmacol20102471019102920008446
   PubMed Web of Science ®Google Scholar
• KaneJMFleischhackerWWHansenLPerlisRPikalovA3rdAssunção-TalbottSAkathisia: an updated review focusing on second-generation antipsychoticsJ Clin Psychiatry200970562764319389331
   PubMed Web of Science ®Google Scholar
• FuruseTHashimotoKFluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptorsAnn Gen Psychiatry201061120205742
   PubMed Web of Science ®Google Scholar
• RamaswamySVijayDWilliamMSattarSPPraveenFPettyFAripiprazole possibly worsens psychosisInt Clin Psychopharmacol2004191454815101571
   PubMed Web of Science ®Google Scholar
• BarnasMEHussainNPetridesGTreatment-emergent psychosis with aripiprazoleJ Clin Psychiatry20056610133916259556
   PubMed Web of Science ®Google Scholar
• ReevesRRMackJEWorsening schizoaffective disorder with aripiprazoleAm J Psychiatry20041617130815229073
   PubMed Web of Science ®Google Scholar
• GroverSSharanPGuptaNAripiprazole worsens psychosis: a case reportPrim Care Companion J Clin Psychiatry20068638038117245466
   PubMedGoogle Scholar
• AhujaNLloydAJAripiprazole and worsening of psychosis: a case reportJ Clin Psychiatry200768580580617504001
   PubMed Web of Science ®Google Scholar
• AhujaNLloydAJWorsening of psychosis in a 30 year old man with undifferentiated schizophreniaAnn Clin Psychiatry200820211311418568584
   PubMed Web of Science ®Google Scholar
• KapustaNDMossahebNBarnasCFischerPAripiprazole-induced psychosis: a case report of reexposure by stepwise up-titrationJ Clin Psychiatry20076891445144617915989
   PubMed Web of Science ®Google Scholar
• LetmaierMPainoldAHollAKGrohmannRVerginHSevere psychotic exacerbation during combined treatment with sripiprazole/ haloperidol after prior treatment with risperidoneInt J Psychiatry Clin Pract132012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• PadalaPRWengelSPPettyFManic episode during treatment with aripiprazoleAm J Psychiatry2007164117217317202565
   PubMed Web of Science ®Google Scholar
• TraberRSchneiterRModestinJA case of aripiprazole-induced maniaPharmacopsychiatry2007401373817327959
   PubMed Web of Science ®Google Scholar
• DonohueAFirst manic episode in a 55-year-old man after initiation of aripiprazolePsychiatry201074373920508807
   PubMedGoogle Scholar
• BenyaminaASamalinLAtypical antipsychotic-induced mania/ hypomania: a review of recent case reports and clinical studiesInt J Psychiatry Clin Pract20121612722122647
   PubMed Web of Science ®Google Scholar
• HolzerLEapCBAripiprazole and suicidalityInt Clin Psychopharmacol200621212512616421465
   PubMed Web of Science ®Google Scholar
• SelvarajVRamaswamySSharmaAWilsonDNew-onset psychosis and emergence of suicidal ideation with aripiprazoleAm J Psychiatry2010167121535153621131415
   PubMed Web of Science ®Google Scholar
• BeersELoonenAJVan GrootheestACSuicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drugNed Tijdschr Geneeskd20061507401402 Dutch16523807
   PubMedGoogle Scholar
• RosenheckRAAripiprazole and perphenazine: no differenceJ Clin Psychiatry200768111812181318052580
   PubMed Web of Science ®Google Scholar
• DuggalHSMendhekarDNHigh-dose aripiprazole in treatment-resistant schizophreniaJ Clin Psychiatry200667467467516669736
   PubMed Web of Science ®Google Scholar
• HughesDMorcosMUse of aripiprazole in treatment resistant schizophreniaJ Psychopharmacol200822892792818308805
   PubMed Web of Science ®Google Scholar
• Jong-YihLSuccessful switch from clozapine to aripiprazole. A case reportJ Clin Psychopharmacol2009291939519142120
   PubMed Web of Science ®Google Scholar
• SpinaEde LeonJMetabolic drug interactions with newer antipsychotics: a comparative reviewBasic Clin Pharmacol Toxicol2007100142217214606
   PubMed Web of Science ®Google Scholar
• UrichukLPriorTIDursunSBakerGMetabolism of atypical antipsychotics: involvement of cytochrome P450 enzymes and relevance for drug-drug interactionsCurr Drug Metab20089541048818537577
   PubMed Web of Science ®Google Scholar
• LimSPraleaCSchnittJBowersMBJrCooperCPossible increased efficacy of low-dose clozapine when combined with aripiprazoleJ Clin Psychiatry20046591284128515367059
   PubMed Web of Science ®Google Scholar
• AshtonAKAripiprazole augmentation of clozapine: in refractory schizophreniaPsychiatry2005221819
   Google Scholar
• ZiegenbeinMSiebererMCalliessITKroppSCombination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophreniaAust N Z J Psychiatry200539984084116168043
   PubMed Web of Science ®Google Scholar
• Abu-TairFKopitzJBergemannNClozapine augmented with aripiprazole in 5 patients with schizophreniaJ Clin Psychopharmacol200626666967117110831
   PubMed Web of Science ®Google Scholar
• ClarkeLALindenmayerJPKaushikSClozapine augmentation with aripiprazole for negative symptomsJ Clin Psychiatry200667467567616669737
   PubMed Web of Science ®Google Scholar
• StonerSCDahmenMMBergesAPetryWMAugmentation of aripiprazole with low-dose clozapinePharmacotherapy200727111599160217963467
   PubMed Web of Science ®Google Scholar
• MossahebNSpindeleggerCAsenbaumSFischerPBarnasCFavourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapineWorld J Biol Psychiatry201011250250520218805
   PubMed Web of Science ®Google Scholar
• HendersonDCKunkelLNguyenDDAn exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophreniaActa Psychiatr Scand2006113214214716423166
   PubMed Web of Science ®Google Scholar
• ZiegenbeinMWittmannGKroppSAripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observationClin Drug Investig2006263117124
   PubMed Web of Science ®Google Scholar
• KarunakaranKTungarazaTEHarborneGCIs clozapine-aripiprazol combination a useful regime in the management of treatment-resistant schizophrenia?J Psychopharmacol200721445345617050662
   PubMed Web of Science ®Google Scholar
• MitsonisCIDimopoulosNPMitropoulosPAAripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot studyProg Neuropsychopharmacol Biol Psychiatry200731237337717092620
   PubMed Web of Science ®Google Scholar
• De RisioAPancheriASimonettiGGiannarelliDStefanuttoLGentileBAdd-on of aripiprazole improves outcome in clozapine-resistant schizophreniaProg Neuropsychopharmacol Biol Psychiatry20113541112111621447367
   PubMed Web of Science ®Google Scholar
• ChangJSAhnYMParkHJAripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trialJ Clin Psychiatry200869572073118370574
   PubMed Web of Science ®Google Scholar
• FleischhackerWWHeikkinenMEOlieJ-PEffects of adjunctive treatment with aripirazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trialInt J Neuropsychopharmacol20101381115112520459883
   PubMed Web of Science ®Google Scholar
• BarbuiCAccordiniSNoseMAripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical careJ Clin Psychopharmacol201131326627321508849
   PubMed Web of Science ®Google Scholar
• MuscatelloMRBrunoAPandolfoGEffect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled studySchizophr Res20111271–3939921262565
   PubMed Web of Science ®Google Scholar
• BenedettiADi PaoloALastellaMAugmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot studyClin Pract Epidemiol Ment Health20106303520648219
   PubMedGoogle Scholar
• EnglischSZinkMCombined antipsychotic treatment involving clozapine and aripiprazoleProg Neuropsychopharmacol Biol Psychiatry20083261386139218407391
   PubMed Web of Science ®Google Scholar
• LiebermanJASaffermanAZPollackSClinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcomeAm J Psychiatry199415112174417527977880
   PubMed Web of Science ®Google Scholar
• MeltzerHYBastaniBKwonKYRamirezLFBurnettSSharpeJA prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary reportPsychopharmacology (Berl)198999SupplS68S722813667
   PubMed Web of Science ®Google Scholar
• JonesPBBarnesTRDaviesLRandomized controlled trial of effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia. Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)Arch Gen Psychiatry200663101079108717015810
   PubMed Web of Science ®Google Scholar
• Cobo GómezJVFusteGCoronasRCombination of aripiprazole and other psychopharmacological treatments in resistant- and multi-resistant patientsCurr Drug Saf20083321021518691004
   PubMedGoogle Scholar
• KaneJMCorrellCUGoffDCA multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapyJ Clin Psychiatry200970101348135719906340
   PubMed Web of Science ®Google Scholar